Opus Genetics, Inc. financial statements
Opus Genetics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 14.2M | 10-K |
| Net income | −USD 49.59M | 10-K |
| Cash and equivalents | USD 45.09M | 10-Q |
| Total debt | USD 1.13M | 10-Q |
Opus Genetics, Inc. financials on 6ix · Opus Genetics, Inc. on 6ix